Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chemclin Diagnostics CoSHSE:688468 -2.62%67 EV-to-FCF is 32.86 as of Jul. 24, 2026, which is 14% below its 10-year median of 38.36. GuruFocus rates SHSE:688468 with a GF Score™ of 67/100 and a GF Value™ of ¥5.75 (Fairly Valued). The stock has 6 warning signs investors should review. Among 99 Medical Diagnostics & Research companies, Chemclin Diagnostics Co ranks worse than 64.65% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Chemclin Diagnostics Co's Enterprise Value is ¥2,038.0 Mil.
Chemclin Diagnostics Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥62.0 Mil. Therefore, Chemclin Diagnostics Co's EV-to-FCF for today is 32.86.
The historical rank and industry rank for Chemclin Diagnostics Co's EV-to-FCF or its related term are showing as below:
SHSE:688468'
s EV-to-FCF Range Over the Past 10 Years
Min: -72.68 Med: 38.36 Max: 140.83
Current: 32.86
During the past 9 years, the highest EV-to-FCF of Chemclin Diagnostics Co was 140.83. The lowest was -72.68. And the median was 38.36.
SHSE:688468's EV-to-FCF is ranked worse than 64.65% of 99
companies
in the Medical Diagnostics & Research industry
Industry Median: 27.22
vs SHSE:688468: 32.86
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Chemclin Diagnostics Co (SHSE:688468) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Chemclin Diagnostics Co's PE Ratio (TTM) for today is calculated as:
Chemclin Diagnostics Co's share price for today is ¥5.57.
Chemclin Diagnostics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.090.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688468 vs TMO, DHR, IDXX: EV-to-FCF Comparison
For the Diagnostics & Research subindustry, Chemclin Diagnostics Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemclin Diagnostics Co EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Chemclin Diagnostics Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Chemclin Diagnostics Co's EV-to-FCF falls into.
Chemclin Diagnostics Co's current Enterprise Value is ¥2,038.0 Mil.
Chemclin Diagnostics Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥62.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chemclin Diagnostics Co (SHSE:688468) has a EV-to-FCF of 32.86 as of Jul. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Chemclin Diagnostics Co and its competitors. This is 14% below median its historical median of 38.36. According to the industry distribution chart, Chemclin Diagnostics Co ranks #64 out of 99 companies in the Medical Diagnostics & Research industry, placing it in the top 64.6%.
Is Chemclin Diagnostics Co's EV-to-FCF too high?
Chemclin Diagnostics Co's current EV-to-FCF of 32.86 is 14% below median its 10-year median of 38.36. The Medical Diagnostics & Research industry median EV-to-FCF is 27.22. Chemclin Diagnostics Co's value of 32.86 is 20.7% above this industry median. Based on the distribution chart, Chemclin Diagnostics Co ranks #64 out of 99 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Chemclin Diagnostics Co has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chemclin Diagnostics Co's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Chemclin Diagnostics Co ranks #64 out of 99 companies for EV-to-FCF. This places Chemclin Diagnostics Co in the lower half of its industry. The industry median EV-to-FCF is 27.22. Chemclin Diagnostics Co's value of 32.86 is 20.7% above this benchmark. While the company's 10-year median is 38.36 vs. the industry median of 27.22, Chemclin Diagnostics Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 27.22, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemclin Diagnostics Co's current EV-to-FCF of 32.86 is 20.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Chemclin Diagnostics Co and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 27.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemclin Diagnostics Co's current EV-to-FCF is 32.86, which is 14% below median its own 10-year median of 38.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemclin Diagnostics Co stock overvalued right now?
Based on GuruFocus' analysis, Chemclin Diagnostics Co (SHSE:688468) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.75, compared to a current price of ¥5.57 — trading 3.1% below its estimated fair value. The current EV-to-FCF is 32.86, which is 14% below median its 10-year median of 38.36 and 20.7% above the Medical Diagnostics & Research industry median of 27.22. Chemclin Diagnostics Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Chemclin Diagnostics Co (SHSE:688468), the current EV-to-FCF is 32.86 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemclin Diagnostics Co (SHSE:688468) Overvalued in 2026?
Based on GuruFocus' analysis, Chemclin Diagnostics Co stock appears to be undervalued.
The current stock price of ¥5.57 is trading 3.1% below its estimated GF Value™ of ¥5.75.
GuruFocus considers Chemclin Diagnostics Co to be Fairly Valued.
Key valuation signals for SHSE:688468:
EV-to-FCF: 32.86 (14% below median its 10-year median of 38.36)
GF Value™: ¥5.75 vs. price of ¥5.57 (3.1% below fair value)
Industry Position: 20.7% above the Medical Diagnostics & Research median (#64 of 99)
No single metric tells the full story. See the SHSE:688468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemclin Diagnostics Co Ltd is engaged in the development, production and sales of clinical immunochemiluminescence diagnostic testing reagents and instruments.
67GF Score
Get the complete analysis for SHSE:688468
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688468 has been successfully added to your 
